PRODUCT DETAIL

Dasatinib Sandoz 20 mg

Code

9822C

MA number

44/0392/18-S

Product Form:

tbl flm 60x20 mg (fľ.HDPE)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EA	BCR-ABL tyrosine kinase inhibitors
L01EA02	Dasatinib

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	12.12.2018
SPC:	SPC_Dasatinib Sandoz 20 mg_09.2023.pdf
PIL:	PIL_Dasatinib Sandoz 20 mg_09.2023.pdf
Safety feature	Yes
Data update:	06.09.2023